INHIBITION OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RESTORES CHOLESTEROL EFFLUX IN THP-1 HUMAN MACROPHAGES EXPOSED TO PLASMA FROM TYPE 1 DIABETES MELLITUS PATIENTS

被引：0
|
作者：
Corletto, J. M. [1 ,3 ]
Accacha, S. [1 ,3 ]
Voloshyna, I. [2 ,3 ]
Siegart, N. [2 ,3 ]
Kasselman, L. [2 ,3 ]
Magana, M. C. [1 ]
DeLeon, J. [2 ,3 ]
Reiss, A. B. [2 ,3 ]
机构：
[1] Winthrop Univ Hosp, Pediat Endocrinol, Mineola, NY 11501 USA
[2] Winthrop Univ Hosp, Med, Mineola, NY 11501 USA
[3] Winthrop Univ Hosp, Winthrop Res Inst, Mineola, NY 11501 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2016年 / 64卷 / 03期
关键词：
D O I：
10.1136/jim-2016-000080.3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：800 / 800
页数：1
相关论文
共 50 条
  • [31] ADIPOCYTE-DERIVED EXOSOMES FROM OBESE SUBJECTS HAVE ATHEROGENIC EFFECTS ON CHOLESTEROL EFFLUX IN THP-1 HUMAN MACROPHAGES
    Siegart, Nicolle M.
    Reiss, Allison B.
    De Leon, Joshua
    Voloshyna, Iryna
    Barlev, Ashley
    Salama, Michael
    Ferrante, Sarah
    Nadler, Evan
    Freishtat, Robert J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (03) : 730 - 730
  • [32] Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease
    Bakker, S. F.
    Tushuizen, M. E.
    Gozutok, E.
    Ciftci, A.
    Gelderman, K. A.
    Mulder, C. J.
    Simsek, S.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (02) : 230 - 235
  • [33] Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages
    Graham, A
    Angell, ADR
    Jepson, CA
    Yeaman, SJ
    Hassall, DG
    ATHEROSCLEROSIS, 1996, 120 (1-2) : 135 - 145
  • [34] Expression of High Mobility Group Box 1 and Receptor for Advanced Glycation End Products in the Gingival Tissues of Periodontitis Patients with Type 2 Diabetes Mellitus
    Raj, Ramya
    Appukuttan, Devapriya
    Subramanian, Sangeetha
    Prakash, P. S. G.
    Crena, Jasmine
    TURKISH JOURNAL OF IMMUNOLOGY, 2023, 11 (02): : 74 - 92
  • [35] Effect of different vasoactive therapies on receptor for advanced glycation end-products (RAGE) plasma levels in patients with type 2 diabetes mellitus
    Brown, LF
    Maxwell, PR
    Panarelli, M
    CLINICA CHIMICA ACTA, 2005, 355 : S346 - S347
  • [36] Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients
    Greifenhagen, Uta
    Frolov, Andrej
    Blueher, Matthias
    Hoffmann, Ralf
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2016, 408 (20) : 5557 - 5566
  • [37] Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients
    Uta Greifenhagen
    Andrej Frolov
    Matthias Blüher
    Ralf Hoffmann
    Analytical and Bioanalytical Chemistry, 2016, 408 : 5557 - 5566
  • [38] Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells
    Choi, Hee-Jung
    Jang, Hye-Jin
    Chung, Tae-Wook
    Jeong, Seung-Il
    Cha, Jaeho
    Choi, Jun-Young
    Han, Chang Woo
    Jang, Yong-Suk
    Joo, Myungsoo
    Jeong, Han-Sol
    Ha, Ki-Tae
    FITOTERAPIA, 2013, 86 : 19 - 28
  • [39] Assessment of Pentosidine as a Marker for Advanced Glycation End Products in Type 2 Diabetes Mellitus Patients
    Jaishankar, Sarath Kumar Jaganathan
    Murali, Amrutha
    Marzooka, Amrin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (02)
  • [40] Role of Advanced Glycation End Products on Aortic Calcification in Patients with Type 2 Diabetes Mellitus
    Sanchis, Pilar
    Rivera, Rosmeri
    Fortuny, Regina
    Rio, Carlos
    Mas-Gelabert, Miguel
    Gonzalez-Freire, Marta
    Grases, Felix
    Masmiquel, Luis
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 16
12345